Margaret K Hahn Selected Research

Margaret K Hahn Research Topics

Disease

24	Weight Gain 12/2023 - 07/2010
23	Schizophrenia (Dementia Praecox) 12/2023 - 12/2010
13	Insulin Resistance 03/2024 - 03/2014
12	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 12/2010
8	Type 2 Diabetes Mellitus (MODY) 02/2024 - 03/2014
8	Mental Disorders (Mental Disorder) 11/2023 - 07/2016
6	Weight Loss (Weight Reduction) 09/2023 - 12/2010
5	Inflammation (Inflammations) 02/2024 - 01/2019
5	Obesity 01/2023 - 02/2013
5	Body Weight (Weight, Body) 01/2023 - 12/2010
4	Dyslipidemias (Dyslipidemia) 01/2023 - 01/2018
4	Treatment-Resistant Schizophrenia 01/2022 - 01/2013
3	Hyperglycemia 01/2023 - 03/2014
2	Prediabetic State (Prediabetes) 01/2024 - 01/2021
2	Bipolar Disorder (Manic Depressive Psychosis) 12/2023 - 01/2023
2	Cognitive Dysfunction 11/2023 - 11/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2021
2	Developmental Disabilities (Developmental Disability) 03/2023 - 01/2023
1	Ischemic Stroke 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Acute Coronary Syndrome 01/2023
1	Neurobehavioral Manifestations 01/2022
1	Overweight 01/2021
1	Morbid Obesity 01/2021
1	Food Addiction 12/2020
1	Bulimia (Binge Eating) 12/2020
1	Hypertension (High Blood Pressure) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Hyperinsulinism (Hyperinsulinemia) 11/2015

Drug/Important Bio-Agent (IBA)

41	Antipsychotic Agents (Antipsychotics)IBA 02/2024 - 07/2010
14	Olanzapine (Zyprexa)FDA Link 02/2024 - 02/2013
12	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 03/2014
10	Metformin (Glucophage)FDA LinkGeneric 01/2024 - 07/2010
8	Insulin (Novolin)FDA Link 11/2023 - 03/2014
8	Clozapine (Clozaril)FDA LinkGeneric 01/2022 - 12/2010
4	LipidsIBA 12/2023 - 01/2017
4	Topiramate (Topamax)FDA LinkGeneric 09/2023 - 07/2010
2	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 11/2023
2	Retinaldehyde (Retinal)IBA 12/2023 - 01/2023
2	semaglutideIBA 09/2023 - 01/2023
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2022 - 01/2022
1	Bromocriptine (Parlodel)FDA LinkGeneric 02/2024
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2024
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2024
1	salicylsalicylic acid (salsalate)IBA 12/2023
1	cagrilintideIBA 09/2023
1	tirzepatideIBA 09/2023
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	adrenic acid (7,10,13,16-docosatetraenoic acid)IBA 01/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	CytokinesIBA 12/2021
1	PrebioticsIBA 03/2021
1	Chlorpromazine (Thorazine)FDA Link 01/2021
1	norclozapineIBA 01/2021
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2021
1	KATP ChannelsIBA 01/2021
1	Pyruvic Acid (Pyruvate)IBA 12/2019
1	Blood Glucose (Blood Sugar)IBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	Insulin ReceptorIBA 11/2017
1	LeptinIBA 01/2017
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2017
1	antiarrhythmic peptide (AAP)IBA 07/2016
1	C-PeptideIBA 03/2014
1	Neuropeptide YIBA 02/2013
1	Peptides (Polypeptides)IBA 02/2013
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Off-Label Use 01/2022
1	Lasers (Laser) 12/2021
1	Duration of Therapy 02/2013